Related references
Note: Only part of the references are listed.Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface - a multicentre randomized single-masked study
Makoto Aihara et al.
ACTA OPHTHALMOLOGICA (2013)
Glaucoma therapy and ocular surface disease: current literature and recommendations
Zane Anwar et al.
CURRENT OPINION IN OPHTHALMOLOGY (2013)
Diurnal and Nocturnal Variations in Aqueous Humor Dynamics of Patients With Ocular Hypertension Undergoing Medical Therapy
Vikas Gulati et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma
Samih Alqawlaq et al.
NANOMEDICINE (2012)
Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement
Elma E. Chang et al.
OPHTHALMOLOGY (2012)
A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
Takanori Mizoguchi et al.
CLINICAL OPHTHALMOLOGY (2012)
Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
Ingrida Januleviciene et al.
CLINICAL OPHTHALMOLOGY (2012)
Corneal Neurotoxicity Due to Topical Benzalkonium Chloride
Joy Sarkar et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension
Robert D. Williams et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Gene therapy for glaucoma
Anna-Maria Demetriades
CURRENT OPINION IN OPHTHALMOLOGY (2011)
Neurotrophic factor delivery as a protective treatment for glaucoma
Thomas V. Johnson et al.
EXPERIMENTAL EYE RESEARCH (2011)
A History of Glaucoma Pharmacology
Tony Realini
OPTOMETRY AND VISION SCIENCE (2011)
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
Hannu Uusitalo et al.
ACTA OPHTHALMOLOGICA (2010)
Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study
Hannu Uusitalo et al.
ACTA OPHTHALMOLOGICA (2010)
Meta-analysis of the Efficacy and Safety of α2-Adrenergic Agonists, β-Adrenergic Antagonists, and Topical Carbonic Anhydrase Inhibitors With Prostaglandin Analogs
Angelo P. Tanna et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Influence of Alkyl Chain Length of Benzalkonium Chloride on Acute Corneal Epithelial Toxicity
Masafumi Uematsu et al.
CORNEA (2010)
Diurnal and Nocturnal Effects of Brimonidine Monotherapy on Intraocular Pressure
John H. K. Liu et al.
OPHTHALMOLOGY (2010)
Periorbital Fat Atrophy - An Unfamiliar Side Effect of Prostaglandin Analogues
Anuradha Jayaprakasam et al.
ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY (2010)
Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
Dietmar Schnober et al.
CLINICAL OPHTHALMOLOGY (2010)
Short-Term Tolerability of Once-Daily Timolol Hemihydrate 0.5%, Timolol Maleate in Sorbate 0.5%, and Generic Timolol Maleate Gel-Forming Solution 0.5% in Glaucoma and/or Ocular Hypertension: A Prospective, Randomized, Double-Masked, Active-Controlled, Three-Period Crossover Pilot Study
Sriram Sonty et al.
CLINICAL THERAPEUTICS (2009)
Topical Beta Blockers in Asthmatic Patients-Is It Safe?
Igor Kaiserman et al.
CURRENT EYE RESEARCH (2009)
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies
Louis B. Cantor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Comparing Diurnal and Nocturnal Effects of Brinzolamide and Timolol on Intraocular Pressure in Patients Receiving Latanoprost Monotherapy
John H. K. Liu et al.
OPHTHALMOLOGY (2009)
Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure
Jin-Wei Cheng et al.
CLINICAL THERAPEUTICS (2008)
Efficacy, safety, and current applications of brimonidine
Scott J. Fudemberg et al.
EXPERT OPINION ON DRUG SAFETY (2008)
Recent advances in pharmacotherapy of glaucoma
S. K. Gupta et al.
INDIAN JOURNAL OF PHARMACOLOGY (2008)
Periorbital changes associated with topical bimatoprost
Theodoros Filippopoulos et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Update on the Mechanism of Action of Topical Prostaglandins for Intraocular Pressure Reduction
Carol B. Toris et al.
SURVEY OF OPHTHALMOLOGY (2008)
Side Effects Associated with Prostaglandin Analog Therapy
Albert Alm et al.
SURVEY OF OPHTHALMOLOGY (2008)
Fixed-combination and emerging glaucoma therapies
David F. Woodward et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
New perspectives in aqueous humor secretion and in glaucoma: The ciliary body as a multifunctional neuroendocrine gland
Miguel Coca-Prados et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2007)
Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma
Vasantha P. Rao et al.
BIODRUGS (2007)
Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1:: An experimental study
Antoine Labbe et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Intraocular pressure-lowering effects of all commonly used glaucoma drugs - A meta-analysis of randomized clinical trials
R van der Valk et al.
OPHTHALMOLOGY (2005)
Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
JHK Liu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study
RK Parrish et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
RS Noecker et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure
HD Jampel et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
New glaucoma medications in the geriatric population: Efficacy and safety
GD Novack et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension
LJ Katz
JOURNAL OF GLAUCOMA (2002)
A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data
JP Nordmann et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery
PR Lichter et al.
OPHTHALMOLOGY (2001)
Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension
S Gandolfi et al.
ADVANCES IN THERAPY (2001)
Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: A 30-day comparison with latanoprost
H DuBiner et al.
SURVEY OF OPHTHALMOLOGY (2001)
Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting
H Barnebey et al.
CLINICAL THERAPEUTICS (2000)
Effects of systemic β-blocker therapy on the efficacy and safety of topical brimonidine and timolol
JS Schuman
OPHTHALMOLOGY (2000)
The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt (R)) as a primary therapy in patients with open-angle glaucoma or ocular hypertension
K Sall
SURVEY OF OPHTHALMOLOGY (2000)
Share Paper
